Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I)

Objective: To compare the differences in adverse effects and efficacy profile between bacillus Calmette-Guerin (BCG) Danish 1331 and BCG Moscow-I strain in management of non-muscle invasive bladder cancer. Methods: Clinical data of 188 cases of non-muscle invasive bladder cancer treated with BCG bet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yuvaraja B. Thyavihally, Preetham Dev, Santosh Waigankar, Abhinav Pednekar, Nevitha Athikari, Abhijit Raut, Archan Khandekar, Naresh Badlani, Ashishkumar Asari
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2022-04-01
Col·lecció:Asian Journal of Urology
Matèries:
Adjuvant bacillus Calmette-Guerin
Bacillus Calmette-Guerin adverse effects
Danish 1331 strain
Intravesical therapy
Moscow-I strain
Non-muscle invasive bladder cancer
Accés en línia:http://www.sciencedirect.com/science/article/pii/S2214388221000394
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars